Effect of inflammation on central nervous system development and vulnerability

Current Opinion in Neurology

Volumn 18, Issue 2, 2005, Pages 117-123

  Hagberg, Henrik ^a   Mallard, Carina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Brain function; Central nervous system; Development; Inflammation; Lipopolysaccharide; Vulnerability

Indexed keywords

ADAPTOR PROTEIN; ALBUMIN; CD14 ANTIGEN; CD45 ANTIGEN; CHEMOKINE; COMPLEMENT; CYCLIC GMP; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MIFEPRISTONE; NITRIC OXIDE; OXYGEN RADICAL; PROSTAGLANDIN; PROSTAGLANDIN E2; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

BLOOD BRAIN BARRIER; BRAIN FUNCTION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; COGNITION; DENDRITE; HUMAN; INFLAMMATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; REVIEW;

EID: 16444378016     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wco.0000162851.44897.8f     Document Type: Review

References (61)

1. Hack M, Flannery DJ, Schluchter M, et al. Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 2002; 346:149-157.
2. Huppi PS, Murphy B, Maier SE, et al. Microstructural brain development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging. Pediatrics 2001; 107:455-460.
3. Vaccarino FM, Ment LR. Injury and repair in developing brain. Arch Dis Child Fetal Neonatal Ed 2004; 89:F190-F192. This is a review of a clinically relevant model in rats in which chronic hypoxia decreases brain weight and cerebral volume, and induces ventriculomegaly and dendritic impairment. Developmental compensatory mechanisms are also discussed.
4. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001; 50:362-553.
5. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns: dry numbers, wet lab, and causal inferences. Early Hum Dev 2004; 79:1-15. Support is provided for the suggestion that infection/inflammation is associated white matter injury according to clinical and experimental studies. However, evidence that inflammation precedes injury is presently lacking.
6. Back SA, Han BH, Luo NL, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002; 22:455-463.
7. Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 2002; 8:25-29.
8. Leviton A, Paneth N, Reuss ML, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res 1999; 46:566-575.
9. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182:675-681.
10. Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996; 174:1433-1440.
11. Duggan PJ, Maalouf EF, Watts TL, et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001; 358:1699-1700.
12. Hagberg H, Peebles D, Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 2002; 8:30-38.
13. Peebles DM, Miller S, Newman JP, et al. The effect of systemic administration of lipopolysaccharide on cerebral haemodynamics and oxygenation in the 0.65 gestation ovine fetus in utero. BJOG 2003; 110:735-743.
14. Mallard C, Welin AK, Peebles D, et al. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res 2003; 28:215-223.
15. Eklind S, Mallard C, Leverin AL, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001; 13:1101-1106.
16. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004; 430:257-263. This review raises new questions regarding the role of TLRs in adaptive immunity and the possibility of alternative mechanisms in microbe sensing.
17. Palsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004; 113:153-162. This review describes TLR-4 signal transduction, including early MyD88- and MAL-dependent and late MyD88-independent mechanisms.
18. Hansen MK, Nguyen KT, Fleshner M, et al. Effects of vagotomy on serum endotoxin, cytokines, and corticosterone after intraperitoneal lipopolysaccharide. Am J Physiol Regul Integr Comp Physiol 2000; 278: R331-R336.
19. Perry VH. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 2004; 18:407-413. This article discusses the communication between systemic inflammation and the CNS, and its potential role in neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and prion disease.
20. Fang C, Yoon S, Tindberg N, et al. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem Pharmacol 2004; 67:1389-1397. This study shows changes in hepatic gene expression after lipopolysaccharide exposure using microarray technique. More than 20 novel potential acute phase proteins and many early transcription factors were identified.
21. Quan N, Stern EL, Whiteside MB, Herkenham M. Induction of proinflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol 1999; 93:72-80.
22. Engblom D, Saha S, Engstrom L, et al. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat Neurosci 2003; 6:1137-1138.
23. Konsman JP, Vigues S, Mackerlova L, et al. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J Comp Neurol 2004; 472:113-129.
24. Wong D, Dorovini-Zis K, Vincent SR. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp Neurol 2004; 190:446-455.
25. Yan E, Castillo-Melendez M, Nicholls T, et al. Cerebrovascular responses in the fetal sheep brain to low-dose endotoxin. Pediatr Res 2004; 55:855-863.
26. Mittermayer F, Pleiner J, Schaller G, et al. Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humans. Eur J Clin Invest 2003; 33:758-761.
27. Young PP, Fantz CR, Sands MS. VEGF disrupts the neonatal blood-brain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency. Exp Neurol 2004; 188:104-114.
28. Groll SD, Ransohoff RM, Cai N, et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol 2004; 187:388-402.
29. Laflamme N, Rivest S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. Faseb J 2001; 15:155-163.
30. Nguyen MD, Julien JP, Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 2002; 3:216-227.
31. Singh AK, Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 2004; 201:197-207. Mass spectrometry revealed that lipopolysaccharide-lipid A ions are present in endothelial cells but not in hypothalamic cells after systemic lipopolysaccharide injections, which indicates that lipopolysaccharide enters the endothelial cells but does not cross the BBB and accumulate in the brain.
32. Stern EL, Quan N, Proescholdt MG, Herkenham M. Spatiotemporal induction patterns of cytokine and related immune signal molecule mRNAs in response to intrastriatal injection of lipopolysaccharide. J Neuroimmunol 2000; 109:245-260.
33. Hosoi T, Okuma Y, Kawagishi T, et al. Bacterial endotoxin induces STAT3 activation in the mouse brain. Brain Res 2004; 1023:48-53.
34. Borsody MK, Weiss JM. The effects of endogenous interleukin-1 bioactivity on locus coeruleus neurons in response to bacterial and viral substances. Brain Res 2004; 1007:39-56.
35. Nadeau S, Rivest S. Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J Neurosci 2003; 23:5536-5544.
36. Duncan JR, Cock ML, Scheerlinck JP, et al. White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr Res 2002; 52:941-949.
37. Debillon T, Gras-Leguen C, Leroy S, et al. Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion. Brain Res Dev Brain Res 2003; 145:39-48.
38. Ornoy A, Altshuler G. Maternal endotoxemia, fetal anomalies, and central nervous system damage: a rat model of a human problem. Am J Obstet Gynecol 1976; 124:196-204.
39. Cai Z, Pan ZL, Pang Y, et al. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 2000; 47:64-72.
40. Urakubo A, Jarskog LF, Lieberman JA, Gilmore JH. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 2001; 47:27-36.
41. Bell MJ, Hallenbeck JM, Gallo V. Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr Res 2004; 56:541-546. This study confirms previous reports that intrauterine inflammation can induce increased expression of some cytokines in the foetal brain.
42. Gayle DA, Beloosesky R, Desai M, et al. Maternal LPS induces cytokines in the amniotic fluid and corticotropin releasing hormone in the fetal rat brain. Am J Physiol Regul Integr Comp Physiol 2004; 286:R1024-R1029. In contrast to the report by Bell et al. [4], in this study there were no changes in foetal CNS cytokines following maternal exposure to lipopolysaccharide. The differences between the studies may be due to different gestational age at exposure, route of lipopolysaccharide administration, or rat strains.
43. Gilmore JH, Jarskog LF, Vadlamudi S. Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat. J Neuroimmunol 2003; 138:49-55.
44. Boisse L, Mouihate A, Ellis S, Pittman QJ. Long-term alterations in neuroimmune responses after neonatal exposure to lipopolysaccharide. J Neurosci 2004; 24:4928-4934. Neonatal rats that were exposed to E. coli lipopolysaccharide exhibited attenuated febrile responses to E. coli lipopolysaccharide as adults. Also, an antigenically dissimilar lipopolysaccharide (Salmonella enteritidis) was equally effective in reducing adult responses to E. coli lipopolysaccharide, suggesting long-term alterations in the innate immune system.
45. Ling Z, Gayle DA, Ma SY, et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 2002; 17:116-124.
46. Goralski KB, Renton KW. Brain inflammation enhances 1-methyl-4-phenyl- pyridinium-evoked neurotoxicity in rats. Toxicol Appl Pharmacol 2004; 196:381-389.
47. Brown AS, Hooton J, Schaefer CA, et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004; 161:889-895. This interesting study showed almost doubled levels of the chemokine interleukin-8 in second trimester serum samples from mothers of offspring that later developed schizophrenia.
48. Fortier ME, Joober R, Luheshi GN, Boksa P. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 2004; 38:335-345.
49. Borrell J, Vela JM, Arevalo-Martin A, et al. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 2002; 26:204-215.
50. Shaw KN, Commins S, O'Mara SM. Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus. Behav Brain Res 2001; 124:47-54.
51. Vereker E, Campbell V, Roche E, et al. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J Biol Chem 2000; 275:26252-26258.
52. Kavanagh T, Lonergan PE, Lynch MA. Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation. Prostaglandins Leukot Essent Fatty Acids 2004; 70:391-397.
53. Watanabe S, Kanada S, Takenaka M, Hamazaki T. Dietary n-3 fatty acids selectively attenuate LPS-induced behavioral depression in mice. Physiol Behav 2004; 81:605-613.
54. Milatovic D, Zaja-Milatovic S, Montine KS, et al. Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivo. J Neuroinflammation 2004; 1:20. This study provides evidence that lipopolysaccharide can induce structural alterations in the hippocampus (dendritic degeneration). However, these changes appear to be transient and the long-term effects are not known.
55. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003; 302:1760-1765. This interesting paper demonstrates that neuroinflammation impairs neurogenesis and enhances apoptosis in the adult brain. Anti-inflammatory agents improved neurogenesis both in response to lipopolysaccharide and irradiation.
56. Filipovic R, Zecevic N. Lipopolysaccharide affects Golli expression and promotes proliferation of oligodendrocyte progenitors. Glia 2004; 49:457-466. This paper suggests that microglial secretion of Golli proteins promotes proliferation of oligodendrocyte precursors if lipopolysaccharide is given in moderate doses, whereas high amounts of lipopolysaccharide decrease proliferation.
57. Hagberg H, Dammann O, Mallard C, Leviton A. Preconditioning and the developing brain. Semin Perinatol 2005 (in press).
58. Ahmed SH, He YY, Nassief A, et al. Effects of lipopolysaccharide priming on acute ischemic brain injury. Stroke 2000; 31:193-199.
59. Toyoda T, Kassell NF, Lee KS. Induction of tolerance against ischemia/ reperfusion injury in the rat brain by preconditioning with the endotoxin analog diphosphoryl lipid A. J Neurosurg 2000; 92:435-441.
60. Eklind S, Mallard C, Arvidsson P, Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing brain. Pediatr Res 2005 (in press).
61. Eklind S, Arvidsson P, Hagberg H, Mallard C. The role of glucose in brain injury following the combination of lipopolysaccharide or lipoteichoic acid and hypoxia-ischemia in neonatal rats. Dev Neurosci 2004; 26:61-67. Lipopolysaccharide induces hypoglycaemia, which could contribute to the enhanced cerebral vulnerability in connection with neuroinflammation.